Table 2.
Clinical and biochemical characteristics of studied women
| PCOS/Overweight n=20 | PCOS/Normal weight n=18 | Non-PCOS/Over weight n=19 | Non-PCOS/Normal weight n=20 | |
|---|---|---|---|---|
| Follicle number | 12.7 ± 3b | 17.2 ± 4.2c, d | 7.2 ± 1.2 | 9.1 ± 2 |
| Age (Y) | 29 ± 4.9 | 28.1 ± 4.1 | 28.1 ± 2.3 | 28.9 ± 4.2 |
| BMI (kg/m2) | 28.4 ± 2.7a | 23 ± 1.9d | 28.1 ±2.1e | 22.5 ± 2 |
| LH (IU/L) | 7.4 ± 4.5a, b | 9.2 ± 6.5c, d | 4.8 ± 2.1e | 6.5 ± 3 |
| FSH (IU/L) | 5.6 ± 1.7b | 5.9 ± 1.7c, d | 7.1 ± 2.5 | 7.2 ± 2.3 |
| LH/FSH | 1.4 ± 0.9b | 1.6 ± 0.8c, d | 0.9 ± 0.1 | 1.0 ± 0.2 |
| Insulin (µmol/L) | 24.7 ± 9.6a | 11.6 ± 2.5c | 19.6 ± 1.8e | 13.7 ± 2.7 |
| Glucose (mg/dl) | 131.9 ± 30.5 | 111.96 ± 14.5c | 120.46 ± 32e | 95.4 ± 14.3 |
| HOMA-IR | 7.3 ± 1.4a | 5.8 ± 0.9c, d | 2.5 ± 1.1 | 2.3 ± 0.4 |
| Testosterone (ng/ml) | 1.9 ± 0.4 | 2.0 ± 0.7 | 1.7 ± 0.4 | 1.2 ± 0.5 |
| Vitamin D (nmol/ml) | 1.6 ± 0.9a, b, c | 4.5 ± 1.7d | 5.2 ± 1.8e | 7.1 ± 1.3 |
Values are referred as mean ± SD. P<0.05 was considered statistically significant.
a; Significant differences between polycystic ovary syndrome (PCOS)/overweight and PCOS/normal weight, b; Significant differences between PCOS/overweight and Non-PCOS/overweight, c; Significant differences between PCOS/normal weight and Non-PCOS/normal weight, d; Significant differences between PCOS/normal weight and Non-PCOS/overweight, e; Significant differences between Non-PCOS/normal weight and Non-PCOS/overweight, BMI; Body mass index, LH; Luteinizing hormone, FSH; Follicle-stimulating hormone, and HOMA-IR; Homeostatic model assessment-insulin resistance.